Centogene N.V. (Nasdaq: CNTG), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, and The Michael...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that the United States Food...
Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of...
Today, Kaia Health announces an important milestone in its commitment to ensuring affordable and frictionless access to clinically validated digital...
Vysioneer, a leading innovator in Oncology AI, is proud to announce a strategic collaboration with MC Medical, a subsidiary of...
Takeda today announced that the U.S. Food and Drug Administration (FDA) has approved HYQVIA® for the treatment of chronic inflammatory...
Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in...
YolTech Therapeutics today announced that the first patient has been dosed with YOLT-201, the company's first in vivo genome editing candidate being...
LANGaware, an innovative digital assessment tool, is excited to announce its transformative collaboration with BThere Healthcare, a pioneering healthcare provider...
Haystack Oncology, a Quest Diagnostics (NYSE: DGX) company, has entered into a collaboration with Rutgers Cancer Institute of New Jersey to use Haystack...
